首页> 外文期刊>European Journal of Pharmacology: An International Journal >The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo.
【24h】

The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivo.

机译:体内缺血/再灌注损伤后,啮齿动物肾脏中环氧合酶2的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

The role of cyclooxygenase-2 (COX-2) in the pathophysiology of renal ischaemia/reperfusion injury is still not fully understood. In order to elucidate the role of COX-2 in ischaemia/reperfusion injury of the kidney, we have evaluated the effects of ischaemia/reperfusion on renal dysfunction and injury in (i) rats treated with either vehicle or the selective COX-2 inhibitor parecoxib, and (ii) wild-type mice or mice in which the gene for COX-2 has been deleted (COX-2 knock-out mice or COX-2(-/-)). Rats were subjected to bilateral renal ischaemia (45 min) and reperfusion (6 h), and received parecoxib (20 mg/kg, i.v.) 30 min prior to ischaemia and 3 h after the commencement of reperfusion. Serum urea, serum creatinine, serum aspartate aminotransferase, creatinine clearance and fractional excretion of sodium were all used as indicators of renal dysfunction and injury. Mice (wild-type and COX-2(-/-)) were subjected to bilateral renal ischaemia (30 min) and reperfusion (24 h) after which renal dysfunction (serum urea and creatinine) and renal injury was assessed by histological analysis. Parecoxib significantly augmented the degree of renal dysfunction and injury caused by ischaemia/reperfusion in the rat. In addition, the degree of renal injury and dysfunction caused by ischaemia/reperfusion was also significantly augmented in COX-2(-/-) mice when compared to their wild-type littermates. These findings support the view that metabolites of COX-2 protect the kidney against ischaemia/reperfusion injury, and (ii) that selective inhibitors of COX-2 may worsen renal dysfunction and injury in conditions associated with renal ischaemia.
机译:尚不完全了解环氧合酶2(COX-2)在肾缺血/再灌注损伤的病理生理中的作用。为了阐明COX-2在肾脏缺血/再灌注损伤中的作用,我们评估了缺血/再灌注对(i)接受媒介物或选择性COX-2抑制剂帕瑞昔布治疗的大鼠肾功能障碍和损伤的影响(ii)野生型小鼠或删除了COX-2基因的小鼠(COX-2基因敲除小鼠或COX-2(-/-))。大鼠经受双侧肾缺血(45分钟)和再灌注(6小时),并在缺血前30分钟和再灌注开始后3小时接受帕瑞昔布(20mg / kg,静脉内)。血清尿素,血清肌酐,血清天冬氨酸转氨酶,肌酐清除率和钠的部分排泄均被用作肾功能不全和损伤的指标。对小鼠(野生型和COX-2(-/-))进行双侧肾脏缺血(30分钟)和再灌注(24 h),然后通过组织学分析评估肾功能障碍(血清尿素和肌酐)和肾损伤。帕瑞昔布显着增加了大鼠缺血/再灌注引起的肾功能不全和损伤程度。此外,与野生型同窝仔相比,COX-2(-/-)小鼠中缺血/再灌注引起的肾脏损伤和功能障碍程度也显着增加。这些发现支持以下观点:COX-2的代谢产物可保护肾脏免于缺血/再灌注损伤;(ii)在与肾脏缺血相关的疾病中,COX-2的选择性抑制剂可加重肾脏功能障碍和损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号